Alzinova AB (publ)

kr 0.34As of Sun 8 Nov 2026, 12:00 UTC
STO:ALZHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (30.97%)
Div yield —
ROE (16.73%)
Biotechnology
Beta (5Y) 1.27
PE TTM —
TSR TTM (77.31%)
Mkt cap kr 108.7M
ROIC (9.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.442
28.38%
(7.60%)
Hold 1|2|1|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
21.34%
26.20%
26.89%
25.24%
Revenuekr M
9.630
9.448
9.896
10.35
(2.12%)
(4.80%)
2.05%
4.66%
Peers (US$10.99M)
Cap (US$)
PE
11.93M
—
Capital
TTM
5Y
10Y
Leveragex
0.317
0.197
0.201
EBIT/Intx
1.502
0.408
0.453
Own earn%
(25.76)
36.34
33.67
Sh yield%
26.80
40.22
39.35
Owners
Insiders/Inst%
1.93
82.47
Short interest%
4.07
SBC / revenue%
5.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
13–20
$1 testx
—
Incr. ROIC%
1